[Clinical significance and occurrence mechanism of hepatitis B virus DNA integration]. [PDF]
Shi YJ, Zhang KX, Li MY, Lu DJ, Chen XM.
europepmc +1 more source
[Differential Expression of FOS-Like Antigen-2 in Tissues of Obese and Type 2 Diabetes Mellitus Mice]. [PDF]
Shen Y, Li J, Li S, Du Q, Li Y, Li Z.
europepmc +1 more source
[Analyzing research advances in single-cell sequencing technology for immunopathological mechanisms in acute-on-chronic liver failure]. [PDF]
Zang SX +5 more
europepmc +1 more source
[Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease]. [PDF]
Wang XY, Sun HM, Gao YH.
europepmc +1 more source
[Alcohol liver disease: immunoregulatory mechanisms and precision therapeutic targets]. [PDF]
Shen HY, Wei LM, Zuo L, Wang H.
europepmc +1 more source
[The E3 ubiquitin ligase KLHL8 degrades HBx protein via the ubiquitin-proteasome pathway and inhibits HBV cccDNA transcription]. [PDF]
Liu ZH +6 more
europepmc +1 more source
[Analysis of the efficacy and safety profile of the use of eltrombopag ethanolamine tablets in patients with cirrhotic thrombocytopenia]. [PDF]
Ning HB, Jin HM, Li K, Peng Z, Shang J.
europepmc +1 more source

